UPDATE 1-Entegris to buy fellow chip industry supplier ATMI for $1.15 bln

Tue Feb 4, 2014 9:51am EST

Related Topics

* Entegris offers $34 for each ATMI share

* Entegris 4th-qtr adj profit/shr $0.18 vs est $0.13

* 4th-qtr revenue $186.3 mln vs est $170.6 mln

* Entregis shares up 15 pct, ATMI up 25 pct (Adds deal details, results, share movement)

Feb 4 (Reuters) - Entegris Inc said it would buy ATMI Inc for $1.15 billion, bringing together two key suppliers of high-purity materials and packaging systems used in the manufacture of semiconductors.

Entegris's offer of $34 per share represents a premium of 26 percent to ATMI's closing price of $26.93 on the Nasdaq on Monday. Entregis's shares rose 15 percent to $11.85 in early trading, while ATMI's shares were trading at $33.76.

The combination will create a leader in advanced process materials, contamination control and wafer handling, the companies said in a statement.

The deal is expected to generate annualized cost savings of about $30 million, the companies said.

Entegris said it would fund the all-cash deal through a combination of cash-on-hand and debt financing.

Entegris also reported better-than expected fourth-quarter results on Tuesday, helped by demand for its liquid and gas filtration and purification technology.

Net income more than doubled to $23.1 million, or 17 cents per share, from $11.3 million, or 8 cents per share, a year earlier, while revenue rose 11 percent to $186.3 million.

The company earned 18 cents per share on an adjusted basis.

Analysts on average had expected earnings of 13 cents per share on revenue of $170.6 million, according to Thomson Reuters I/B/E/S.

ATMI said its income from continuing operations more than halved to $6.4 million, or 19 cents per share, in the quarter ended Dec. 31.

ATMI, which said in November that it was exploring strategic options, sold its LifeSciences business to Pall Corp for $185 million in December. (Reporting By Sampad Patnaik in Bangalore; Editing by Ted Kerr)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.